エーザイ、第13回アルツハイマー病臨床試験会議（CTAD）においてアルツハイマー病／認知症領域の開発品に関する最新データを発表 Eisai Oct 28, 2020 09:00 JST Read More
Eisai and JD Health Establish JV Company in China to Implement Health Service Platform Eisai Oct 28, 2020 08:01 HKT/SGT Read More
Endpoints News Presents "Why Australia and Agilex Biolabs for your Next Clinical Trial" for Bio Europe 2020 Agilex Biolabs Oct 27, 2020 13:00 JST Read More
Global Coalition for Adaptive Research・アムジェン・エーザイ、COVID-19グローバル試験に最初の患者様が登録されたことを発表 Eisai Oct 27, 2020 09:00 JST Read More
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies Eisai Oct 26, 2020 15:52 HKT/SGT Read More
Leading U.S. Government-Accredited Lab Confirms Path-Away(R) Natural Active Ingredient Can Kill Actual COVID-19 Virus Within Two Minutes, First In The World Holista CollTech Ltd Oct 20, 2020 12:00 JST Read More
Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures Eisai Oct 16, 2020 12:44 HKT/SGT Read More
Woori BMO Group Comments on Finance of America Set for IPO Woori BMO Group Oct 16, 2020 06:00 JST Read More
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System Olympus Oct 12, 2020 02:00 HKT/SGT Read More
Moms on Watch: Ni-Q Summary Judgement Illustrates Prolacta's Deceptive Business Practices Moms on Watch Oct 09, 2020 08:00 JST Read More
The University of Tokyo and Eisai Announce Research Collaboration for the Development and Drug Discovery of Targeted Protein Degradation Technology Eisai Oct 08, 2020 13:18 HKT/SGT Read More
NEC OncoImmunity AS and Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 using Artificial Intelligence NEC Corporation Oct 08, 2020 11:43 HKT/SGT Read More
Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers NEC Corporation Oct 06, 2020 16:08 HKT/SGT Read More
エーザイ、TLR4拮抗剤エリトランおよび抗FKN 抗体E6011を用いたCOVID-19治療薬の開発を目指す産学官共同研究開発契約を締結し、非臨床研究活動を開始 Eisai Oct 06, 2020 14:00 JST Read More
Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded Eisai Oct 06, 2020 11:07 HKT/SGT Read More
Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea Eisai Sep 30, 2020 14:06 HKT/SGT Read More
